Literature DB >> 16505140

A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.

Lars Kjer-Nielsen1, Natalie A Borg, Daniel G Pellicci, Travis Beddoe, Lyudmila Kostenko, Craig S Clements, Nicholas A Williamson, Mark J Smyth, Gurdyal S Besra, Hugh H Reid, Mandvi Bharadwaj, Dale I Godfrey, Jamie Rossjohn, James McCluskey.   

Abstract

Little is known regarding the basis for selection of the semi-invariant alphabeta T cell receptor (TCR) expressed by natural killer T (NKT) cells or how this mediates recognition of CD1d-glycolipid complexes. We have determined the structures of two human NKT TCRs that differ in their CDR3beta composition and length. Both TCRs contain a conserved, positively charged pocket at the ligand interface that is lined by residues from the invariant TCR alpha- and semi-invariant beta-chains. The cavity is centrally located and ideally suited to interact with the exposed glycosyl head group of glycolipid antigens. Sequences common to mouse and human invariant NKT TCRs reveal a contiguous conserved "hot spot" that provides a basis for the reactivity of NKT cells across species. Structural and functional data suggest that the CDR3beta loop provides a plasticity mechanism that accommodates recognition of a variety of glycolipid antigens presented by CD1d. We propose a model of NKT TCR-CD1d-glycolipid interaction in which the invariant CDR3alpha loop is predicted to play a major role in determining the inherent bias toward CD1d. The findings define a structural basis for the selection of the semi-invariant alphabeta TCR and the unique antigen specificity of NKT cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505140      PMCID: PMC2118261          DOI: 10.1084/jem.20051777

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  70 in total

1.  Macromolecular TLS refinement in REFMAC at moderate resolutions.

Authors:  Martyn D Winn; Garib N Murshudov; Miroslav Z Papiz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  Infection, autoimmunity, and glycolipids: T cells detect microbes through self-recognition.

Authors:  Mitchell Kronenberg; Yuki Kinjo
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

3.  Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.

Authors:  Dirk M Zajonc; Carlos Cantu; Jochen Mattner; Dapeng Zhou; Paul B Savage; Albert Bendelac; Ian A Wilson; Luc Teyton
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

4.  CD1d antigen presentation: treats for NKT cells.

Authors:  Dale I Godfrey; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2005-08       Impact factor: 25.606

5.  The crystal structure of human CD1d with and without alpha-galactosylceramide.

Authors:  Michael Koch; Victoria S Stronge; Dawn Shepherd; Stephan D Gadola; Bini Mathew; Gerd Ritter; Alan R Fersht; Gurdyal S Besra; Richard R Schmidt; E Yvonne Jones; Vincenzo Cerundolo
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

6.  High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.

Authors:  Fleur E Tynan; Natalie A Borg; John J Miles; Travis Beddoe; Diah El-Hassen; Sharon L Silins; Wendy J M van Zuylen; Anthony W Purcell; Lars Kjer-Nielsen; James McCluskey; Scott R Burrows; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

7.  Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells.

Authors:  Venkataraman Sriram; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Eur J Immunol       Date:  2005-06       Impact factor: 5.532

8.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

9.  Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.

Authors:  John R Ortaldo; Howard A Young; Robin T Winkler-Pickett; Earl W Bere; William J Murphy; Robert H Wiltrout
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 10.  CD1: antigen presentation and T cell function.

Authors:  Manfred Brigl; Michael B Brenner
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  51 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

2.  Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.

Authors:  Onisha Patel; Daniel G Pellicci; Adam P Uldrich; Lucy C Sullivan; Mugdha Bhati; Melissa McKnight; Stewart K Richardson; Amy R Howell; Thierry Mallevaey; Jingjing Zhang; Romain Bedel; Gurdyal S Besra; Andrew G Brooks; Lars Kjer-Nielsen; James McCluskey; Steven A Porcelli; Laurent Gapin; Jamie Rossjohn; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  CD1d-lipid antigen recognition by the γδ TCR.

Authors:  Adam P Uldrich; Jérôme Le Nours; Daniel G Pellicci; Nicholas A Gherardin; Kirsty G McPherson; Ricky T Lim; Onisha Patel; Travis Beddoe; Stephanie Gras; Jamie Rossjohn; Dale I Godfrey
Journal:  Nat Immunol       Date:  2013-09-29       Impact factor: 25.606

4.  αβ T cell antigen receptor recognition of CD1a presenting self lipid ligands.

Authors:  Richard W Birkinshaw; Daniel G Pellicci; Tan-Yun Cheng; Andrew N Keller; Maria Sandoval-Romero; Stephanie Gras; Annemieke de Jong; Adam P Uldrich; D Branch Moody; Dale I Godfrey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

5.  A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Authors:  Kwok S Wun; Garth Cameron; Onisha Patel; Siew Siew Pang; Daniel G Pellicci; Lucy C Sullivan; Santosh Keshipeddy; Mary H Young; Adam P Uldrich; Meena S Thakur; Stewart K Richardson; Amy R Howell; Petr A Illarionov; Andrew G Brooks; Gurdyal S Besra; James McCluskey; Laurent Gapin; Steven A Porcelli; Dale I Godfrey; Jamie Rossjohn
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

6.  The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells.

Authors:  Isaac Engel; Meng Zhao; Dietmar Kappes; Ichiro Taniuchi; Mitchell Kronenberg
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

7.  Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells.

Authors:  Jing Wang; Yali Li; Yuki Kinjo; Thien-Thi Mac; Darren Gibson; Gavin F Painter; Mitchell Kronenberg; Dirk M Zajonc
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-30       Impact factor: 11.205

Review 8.  Coevolution of T-cell receptors with MHC and non-MHC ligands.

Authors:  Caitlin D Castro; Adrienne M Luoma; Erin J Adams
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

Review 9.  CD1 mediated T cell recognition of glycolipids.

Authors:  Dirk M Zajonc; Mitchell Kronenberg
Journal:  Curr Opin Struct Biol       Date:  2007-10-24       Impact factor: 6.809

10.  Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants.

Authors:  Frank A Looringh van Beeck; Peter Reinink; Roel Hermsen; Dirk M Zajonc; Marielle J Laven; Axel Fun; Milana Troskie; Nico J Schoemaker; Darshana Morar; Johannes A Lenstra; Lonneke Vervelde; Victor P M G Rutten; Willem van Eden; Ildiko Van Rhijn
Journal:  Mol Immunol       Date:  2009-01-30       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.